may be also applicable for the decision of revascularization strategy and evaluation of need for more intensive risk modification in addition to SS in clinical practice. The SS has been used as a powerful stratification tool allowing standardized assessment of coronary disease extent and guidance of revascularization strategies of PCI and CABG for research purposes and daily practice based on the findings of SYNTAX trial that patient with low SS had similar clinical outcomes after PCI compared with CABG and that PCI was inferior than CABG in patients with higher SS. 8) Contrast to the SYNTAX trial, there was no significant interaction between SS and revascularization method on clinical outcomes in recent major trials, Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis (NOBLE) and Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) including patients with left main disease. 9)10) High variability and limited functional significance of SS and post-PCI SS should be carefully considered in interpretation and utility of SS. Considering advancements in percutaneous devices, procedural techniques and strategies, SS may not have an absolute value for evaluation of anatomical severity in terms of therapeutic difficulty. Nevertheless, it is still valid to play an important role as a systematic scoring system in which each anatomical characteristic should be recognized as a detrimental factor and dealt with by further validation in contemporary PCI era. SS and SS II should be standardized measurements for assessment of disease severity and risk stratification in patients with left main coronary disease or multivessel disease until then, and its clinical utility for decision of revascularization methods and strategy of risk modification should be further debated. Currently, Kang et al. 7) claims that SS is still valuable for risk stratification in contemporary DES era. Given that both SS and SS II were calculated and acquired at a core lab which may enable more accurate evaluation of disease severity, SS and SS II may be more practical and feasible for risk stratification in such conditions.
